Schrodinger, Inc. EBITDA 2019-2024 | SDGR
Schrodinger, Inc. ebitda from 2019 to 2024. Ebitda can be defined as earnings before interest, taxes, depreciation and amortization.
| Schrodinger, Inc. Annual EBITDA (Millions of US $) |
|
|---|---|
| 2023 | $-172 |
| 2022 | $-142 |
| 2021 | $-109 |
| 2020 | $-57 |
| 2019 | $-35 |
| 2018 | $-25 |
| Schrodinger, Inc. Quarterly EBITDA (Millions of US $) |
|
|---|---|
| 2024-09-30 | $-67 |
| 2024-06-30 | $-51 |
| 2024-03-31 | $-66 |
| 2023-12-31 | $-28 |
| 2023-09-30 | $-55 |
| 2023-06-30 | $-60 |
| 2023-03-31 | $-29 |
| 2022-12-31 | $-27 |
| 2022-09-30 | $-45 |
| 2022-06-30 | $-42 |
| 2022-03-31 | $-28 |
| 2021-12-31 | $-22 |
| 2021-09-30 | $-34 |
| 2021-06-30 | $-30 |
| 2021-03-31 | $-23 |
| 2020-12-31 | $-16 |
| 2020-09-30 | $-15 |
| 2020-06-30 | $-16 |
| 2020-03-31 | $-11 |
| 2019-12-31 | $-7 |
| 2019-09-30 | $-10 |
| 2019-06-30 | $-13 |
| 2019-03-31 | $-5 |
| 2018-12-31 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | MEDICAL INFO SYS | $1.650B | $0.217B |
| Schr?dinger Inc. provides computational platforms to accelerate drug discovery and materials design deployed by biopharmaceutical and industrial companies, academic institutions and government laboratories. Schr?dinger Inc. is based in NEW YORK. | |||